​FDA 510(k) clearance received for the new minimal invasive thoracolumbar posterior fixation system PERLA® TL MIS

After getting the CE marking, Spineart is proud to announce that we received the FDA 510(k) clearance for the new Minimal Invasive Thoracolumbar Posterior Fixation System, PERLA® TL MIS on January 15th, 2021.

PERLA® TL MIS is a comprehensive system including polyaxial screws with Extended Tabs which enable a connection to different rod diameters. It contributes to the treatment of spinal pathologies through Percutaneous and Minimal Invasive Surgeries and perfectly complements the new PERLA® TL solutions designed for the treatment of degenerative pathologies.

Further extensions of the PERLA® TL solution are expected to come.

Related

Related items
Date - Category Illustration Title Excerpt
  • Corporate
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
  • Produits
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...
  • BAGUERA® C
Spineart today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its innovative cervical disc prosthesis, met the...